The size of the global poultry diagnostics market is forecasted to be worth USD 777.86 million by 2029 from USD 472.16 million in 2024, registering a CAGR of 10.5% between 2024 and 2029.
Zoonotic means the bug/disease can be passed from one species to another. Poultry infected by the disease affects the consumers of its products. One of those diseases is salmonella in chickens. CDC estimates that over 1.2 million people died from salmonella last year, and about 450 died. Chickens carry salmonella, and improper handling of the flock can cause the meat to contaminate and affect the consumer.
Poultry diagnostic tests are essential for disease detection and monitoring and help deploy control measures for poultry diseases. The most prevalent diseases observed among the poultry population include avian influenza, Newcastle disease, infectious bronchitis, colibacillosis, mycoplasmosis, chicken anemia, avian reovirus, and others. The global poultry diagnostics market accounted for significant growth in the past years and is anticipated to have the highest CAGR during the forecast period. The rising disease prevalence is majorly driving the demand for diagnostic tests and products, expanding the market share. For Instance, in July 2022, the U.S. Department of Agriculture (USDA) reported that 40.09 million birds in 36 U.S. states were infected. Out of 382 flocks that tested positive for the virus, 186 were commercial, and 196 were backyard flocks. The increasing demand for poultry and its products among people in various regions and stringent food safety regulations are accelerating the demand for poultry diagnostics, contributing to the expansion of market size. The growing investments by the government and non-government organizations in extending veterinary care for poultry farmers will provide market growth opportunities in the coming years.
The growth of the poultry diagnostics market is attributed to factors such as the increasing incidence of zoonotic diseases associated with poultry, growing consumer awareness regarding food safety, and increasing awareness regarding animal health. Increasing consumption of poultry products, their derivatives, and meat, growing livestock population every day, and increasing animal healthcare expenditure in developed and emerging regions also assist in the market's growth. Emerging markets such as China, India, and Brazil offer enormous opportunities for market growth. The growth of the Asia-Pacific market is mainly due to the increased number of livestock in the region, the increased demand for poultry foods, and the increased awareness of animal health, especially in India and China. Also, the spread of bird flu and Newcastle disease in the region is helping the market grow.
The primary factor driving poultry diseases is the rising prevalence of poultry diseases, which demands diagnostics that contribute to market share growth. According to a study published by the Infection, Genetics, and Evolution Journal in 2022, different levels of avian influenza were reported in different backyards, commercial poultry, and wild birds in Bangladesh. The prevalence of household chicken across Bangladesh was 13.8%, 15.0% in layer poultry, and 12.5% in broiler chickens. Additionally, according to data published between April and June 2023 by the European Centre for Disease Prevention and Control (ECDC), 98 domestic and 634 wild birds were infected with the avian influenza A (H5N1) virus. The market players are increasing investments in research activities to analyze different diseases affecting poultry, especially chickens. These companies are making strategic mergers and acquisitions to strengthen their portfolio in veterinary care.
Rapisignificant factors restraining the global poultry diagnostics market growth are the poultry test kits and the need for more professionals in developing countries, unfavorable reimbursement policies, and a lack of awareness in underdeveloped countries, which are more likely to impede the market growth. However, the recent global COVID-19 pandemic has reduced poultry consumption, which is expected to hurt short-term market developments. However, insufficient awareness of animal health in these regions could adversely affect market growth. Over the forecast period, high production costs, increased feed costs, and trade disputes in the poultry industry may somewhat hinder this market.
During the first quarter of 2020, the pandemic hurt market growth. COVID-19 first arrived as a regional pandemic and became a global pandemic. COVID-19 is an infectious disease that transmits quickly from person to person; to control the transmission, all the governments have imposed nationwide lockdowns and a ban on transportation modes. The pandemic has affected all sectors of the economy except the healthcare sector. An increase in COVID-19 prevalence has disrupted poultry diagnostic procedures. All the poultry diagnostic procedures were postponed as the nation focused on combatting the coronavirus. However, after the uplift of the lockdown, poultry diagnostics gained momentum. There has been a vast demand for poultry products globally, and demand and use for eggs in multiple sectors have created market growth. However, despite the negative impact created by COVID-19, the market is projected to gain growth during the forecast period.
|
REPORT METRIC |
DETAILS |
|
Market Size Available |
2023 to 2029 |
|
Base Year |
2023 |
|
Forecast Period |
2024 to 2029 |
|
Segments Analysed |
By Test Type, Disease Type, Services, and Region |
|
Various Analyses Covered |
Global, Regional & Country Level Analysis, Segment-Level Analysis, DROC, PESTLE Analysis, Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview on Investment Opportunities |
|
Regions Analysed |
North America, Europe, Asia Pacific, Latin America, Middle East & Africa |
|
Market Leaders Profiled |
IDEXX Laboratories, QIAGEN, Thermo Fisher Scientific, Zoetis, GD Animal Health, IDVet, AffiniTech, AgroBioTek Internacional, BioNote, BioChek, Boehringer Ingelheim, MEGACORP Diagnostik GmbH, and BioinGentech Biotechnologies. |
Based on the test type, the enzyme-linked adsorption assay (ELISA) segment market share of 51.4% dominated the poultry diagnostics market in 2023. ELISA (enzyme-linked immunoassay) tests are widely used to identify antibodies in the blood. Tests have been a significant source of income for the poultry diagnostics industry. Efficacy in checking for infectious diseases like avian influenza, widespread in developed countries, is essential for the market. ELISA studies have since been shown to be exceptionally reliable and cost-effective for end-users. This factor has improved segment acceptance. Consumables such as diluents and buffers are also less expensive than other diagnostic options, which helps to drive demand. Most companies in the market offer a wide range of products for ELISA tests due to increasing technological advancements in the industry.
The Polymerase Chain Reaction (PCR) segment is expected to grow significantly during the forecast period. The PCR test amplifies DNA to detectable levels to specifically identify disease agents. This increases the preference for this technology as it rapidly detects pathogens, which drives the segment's growth. The increasing research and development activities and partnerships between the market players are estimated to drive market share growth further.
Based on the disease type, the avian influenza segment dominated the poultry diagnostics market with a market share of 27.1% in 2023. The segment growth is expected to have a significant CAGR of 12.0% during the forecast period. The prevalent pathogenic type infects domestic birds, causing respiratory diseases, decreased egg production, and subclinical infections. In a few cases, the high pathogenic (HPAI) variant of the virus has been found to affect domestic flocks. The elevated pathogenic kind causes systemic diseases and mortality.
Avian Salmonellosis is the most common bacteria-caused disease. Salmonella infections cause infections like Pullorum fever, paratyphoid, and fowl typhoid. Chicken and turkey are the most frequent sources of Salmonella contamination. In July 2022, the U.S. Department of Agriculture (USDA) reported 40.09 million birds in 36 U.S. states to be infected with highly pathogenic avian influenza.
The infectious bursal disease segment held the second-largest market. It is a highly contagious viral infection that affects young chickens and turkeys. A high poultry population in major countries affected by infectious bursal disease drives the segment's growth.
Based on services, the Bacteriology segment holds a significant share in the market in terms of service due to regular bacterial testing on poultry to prevent the spread of zoonotic diseases like salmonellosis, pasteurellosis, and mycoplasmosis. Bacteriology services encompass the isolation, identification, and characterization of bacterial pathogens responsible for various poultry diseases. The food safety regulations and consumer demand for safe poultry products have enhanced the focus on bacterial pathogens in poultry. This has shifted the focus of poultry producers and processors to depend heavily on bacteriology to ensure the safety standards of the poultry products. All these factors are augmenting the segment growth.
The North American region dominated the global poultry diagnostics market with the highest revenue in 2023 and is anticipated to dominate during the forecast period. The presence of significant market players in the region and expanding research from public and private organizations are majorly driving the regional market growth. For Instance, in November 2022, the Canadian government invested USD 1.5 million through the Canadian Agricultural Partnership to increase biosecurity efforts for reducing the spread of highly pathogenic avian influenza. North America is expected to occupy the largest share of this market, with 40.6% in 2023, followed by Europe. An increase in the advanced infrastructure concerning animal health and extensive distribution systems in this region drives market growth. The United States holds a significant market share in North America's poultry diagnostics market. Increasing poultry production and improving infrastructure for animal health are boosting market growth in the region. Canada is known for its large production of eggs, and it is expected to maintain the most significant production.
Europe is one of the world's largest poultry producers and a large exporter of poultry products. The growing poultry production enhances the poultry diagnostic market. In Europe, the U.K. poultry diagnostic market contributed the largest share, and most slaughtered animals are boiled chicken. Increased disease outbreaks and the rising prevalence of zoonotic diseases contribute to market growth. The market is forecasted to share a lucrative share with the European market. The U.K. government has introduced changes to boost animal welfare, biosecurity, and poultry producers' compliance since November 2021.
The Asia Pacific is the most significant poultry production player globally and is expected to have the highest CAGR during the forecast period. China and India significantly influence the APAC market, and the support will likely continue throughout the forecast period. The growing poultry farming, rising demand for poultry products among consumers, and the escalation in poultry diseases are primary factors estimated to augment the regional market growth. According to Our World Data, in Australia, the poultry population grew by 10% in 2021 from 2020.
The Latin American region is estimated to have a moderate growth rate during the forecast period due to increasing government investments in enhancing the poultry industry. The increasing awareness among people regarding poultry diseases fuels the market growth rate across the region.
Middle East African countries are projected to increase the market growth of the poultry diagnostic market. Growing demand for poultry-derived food products and the rising prevalence of zoonotic diseases are boosting market growth.
Some promising companies dominating the global poultry diagnostics market profiled in this report are IDEXX Laboratories, QIAGEN, Thermo Fisher Scientific, Zoetis, GD Animal Health, IDVet, AffiniTech, AgroBioTek Internacional, BioNote, BioChek, Boehringer Ingelheim, MEGACORP Diagnostik GmbH, and BioinGentech Biotechnologies.
Key strategic initiatives taken by leading market players include mergers and acquisitions, new product launches, and expanded manufacturing.
By Test Type
By Disease Type
By Services
By Region
Frequently Asked Questions
The global poultry diagnostics market was valued at USD 427.3 Million in 2023.
Zoetis Inc., QIAGEN N.V., Thermo Fisher Scientific Inc., IDEXX Laboratories Inc., and Biochek BV. are some of the notable companies in the poultry diagnostics market.
The rising demand for poultry products, rising incidence of poultry diseases, growing awareness about food safety and animal health, and the need to improve the efficiency and profitability of poultry production are majorly fueling the growth of the poultry diagnostics market..
The accuracy and reliability of diagnostic tests, the cost and availability of diagnostic tools and services, and the need for trained personnel to perform and interpret diagnostic tests are some of the major challenges to the poultry diagnostics market.
Related Reports
Access the study in MULTIPLE FORMATS
Purchase options starting from $ 1800
Didn’t find what you’re looking for?
TALK TO OUR ANALYST TEAM
Need something within your budget?
NO WORRIES! WE GOT YOU COVERED!
Call us on: +1 888 702 9696 (U.S Toll Free)
Write to us: [email protected]
Reports By Region